Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 5, 2014, Pages 867-872

  Xing, Ligang ^a   Liang, Yemin ^b   Zhang, Jiandong ^b   Wu, Peipei ^a   Xu, Deguo ^b   Liu, Fengjun ^b   Yu, Xinshuang ^b   Jiang, Zhongmin ^b   Song, Xiaoming ^b   Zang, Qi ^b   Wang, Wei ^b  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

Author keywords

Capecitabine; Chemoradiotherapy; Cisplatin; Elderly patients; Esophageal cancer

Indexed keywords

CAPECITABINE; CISPLATIN;

ACUTE DIARRHEA; ACUTE TOXICITY; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG RESPONSE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; FEMALE; GERIATRIC DISORDER; HAND FOOT SYNDROME; HUMAN; INTERMETHOD COMPARISON; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION ESOPHAGITIS; RADIATION INJURY; RETROSPECTIVE STUDY; SEQUENTIAL CHEMORADIOTHERAPY; SKIN DISEASE; THERAPY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84901600619     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1615-5     Document Type: Article

References (24)

1. al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284 (Pubitemid 27020584)
2. Anderson SE, Minsky BD, Bains M, Hummer A, Kelsen D, Ilson DH (2007) Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer 96:1823-1827. doi:10.1038/sj.bjc.6603821 (Pubitemid 46912031)
3. Bedenne L, Michel P, Bouche O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160-1168. doi:10.1200/JCO.2005.04.7118 (Pubitemid 46640561)
4. Bonavina L, Incarbone R, Saino G, Clesi P, Peracchia A (2003) Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus 16:90-93. doi:10.1046/j.1442-2050.2003.00300.x (Pubitemid 36992379)
5. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623-1627. doi:10.1001/jama.281.17.1623 (Pubitemid 29211772)
6. CTEP: Common Terminology Criteria for Adverse Events, Version 3.0. (2006) DCTD, NCI, NIH, DHHS. (http://ctep.cancer.gov)
7. Daly JM, Fry WA, Little AG et al (2000) Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 190:562-572. doi:10.1016/S1072-7515(00)00238-6
8. Kim JG, Sohn SK, Kim DH et al (2005) Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 93:1117-1121. doi:10.1038/sj.bjc.6602849 (Pubitemid 41670695)
9. Koo DH, Park SI, Kim YH et al (2011) Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Cancer Chemother Pharmacol 69:655-663. doi:10.1007/s00280-011-1750-5
10. Lee SS, Kim SB, Park SI et al (2007) Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer. Jpn J Clin Oncol 37:829-835. doi:10.1093/jjco/hym117 (Pubitemid 350259001)
11. Lee J, Im YH, Cho EY et al (2008) A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 62:77-84. doi:10.1007/s00280-007-0577-6 (Pubitemid 351537848)
12. Lee SJ, Ahn BM, Kim JG et al (2009) Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study. J Korean Med Sci 24:120-125. doi:10.3346/jkms.2009.24.1.120
13. Li BS, Zhou T, Wang ZT et al (2009) Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma. Radiother Oncol 93:458-461. doi:10.1016/j.radonc.2009.08.002
14. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. doi:10.3322/canjclin.55.2.74
15. Rodel C, Grabenbauer G, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104. doi:10.1200/JCO.2003.02.505
16. Schuller J, Cassidy J, Dumont E et al (2000) Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 45:291-297. doi:10.1007/s002800050043 (Pubitemid 30151522)
17. Smith GL, Smith BD, Buchholz TA et al (2009) Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: the SER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74:482-489. doi:10.1016/j.ijrobp.2008.08.046
18. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317. doi:10.1200/JCO.2005.00.034 (Pubitemid 46218723)
19. Suntharalingam M, Moughan J, Coia LR et al (2005) Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23:2325-2331. doi:10.1200/JCO.2005.00.448 (Pubitemid 46218725)
20. Takeuchi S, Ohtsu A, Doi T et al (2007) A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer. Am J Clin Oncol 30:607-611. doi:10.1097/COC.0b013e3180ca7c84 (Pubitemid 350307186)
21. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216. doi:10.1093/jnci/92.3.205
22. Tougeron D, Di Fiore F, Thureau S et al (2008) Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer 99:1586-1592. doi:10.1038/sj.bjc.6604749
23. van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084. doi:10.1056/NEJMoa1112088
24. Wakui R, Yamashita H, Okuma K et al (2010) Esophageal cancer: definitive chemoradiotherapy for elderly patients. Dis Esophagus 23:572-579. doi:10.1111/j.1442-2050.2010.01062.x